Tag Archives: WuXi Biologics

Hong Kong listed WuXi Biologics to operate Bayer’s final drug product manufacturing plants in Leverkusen, Germany

Plants in Leverkusen will be operated by WuXi Biologics and will serve as a back-up site for final product manufacturing of Kovaltry™

(PRESS RELEASE) LEVERKUSEN, 16-Jan-2020 — /EuropaWire/ —  Life science, health care and nutrition global enterprise Bayer announced that the leading global open-access biologics technology firm WuXi Biologics (WuXi Bio), listed in Hong Kong (stock code: 2269.HK), through its subsidiary in … Read the full press release